News

Number of new prostate cancer cases per 100,000 men: 114.9 white men; 188.7 black men.

An Improved Prostate Cancer Biomarker Test May Help Men Avoid Unnecessary Biopsy

POSTED: April 29, 2024
SOURCE: Cancer Prevention Science Blog
AUTHOR: Alyssa M. Voss, M.P.H.

Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy after an elevated prostate-specific antigen (PSA) test from those…
Virus particles surround three human figures with their livers highlighted. One figure has a healthy liver, one has chronic liver disease and one has liver cancer.
NIH scientists develop blood test to help improve liver cancer screening
Scientists have developed a new test that can help identify people who are likely to develop hepatocellular carcinoma (HCC), the most common form of liver cancer. The approach uses a simple blood test to check for the patient’s previous exposure to certain viruses. A study of the new approach was… Learn more
POSTED: 6/11/2020
SOURCE: NCI Press Release
EsoCheck and EsoGuard infographic
New Technology Gives Patients Access to a 5-Minute, Office-Based Test to Identify Risk for Esophageal Cancer
EsoCheck™ and EsoGuard™ NCI Annual Plan & Budget Proposal for Fiscal Year 2020 (PDF, 17.4 MB) A new technology coupled with a new biomarker test now in clinical trials are giving patients timely access to a quick, accurate and less invasive way to… Learn more
POSTED: 6/1/2020
SOURCE: Cancer Prevention Science Blog
A nurse consults with a patient during Coronavirus quarantine.
How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find Out
With the sudden explosion of the COVID-19 pandemic, we are all living with a great deal of fear, uncertainty, and anxiety. As an oncologist and cancer researcher, I know that those feelings are heightened for many people with cancer.
POSTED: 5/21/2020
SOURCE: NCI Cancer Currents Blog